Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Higher viral loads are associated with a greater risk of death among cancer and non-cancer patients hospitalized with coronavirus disease 2019 (COVID-19), researchers report September 15 in the journal Cancer Cell.

17 Sep 2020

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Sep 2020

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

In a study published on the bioRxiv preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to inhibit SARS-CoV-2 infection in human nasal tissue in vitro.

16 Sep 2020

Changes in risk perception and protective behavior during coronavirus pandemic

In the first week of the coronavirus pandemic, people living in the United States underestimated their chances of catching the virus, or of getting seriously ill from the virus, according to a recently published Caltech-led study.

16 Sep 2020

Labeling e-cigarette emissions as 'chemicals' or 'aerosols' increases the perceived risk of exposure

A new study led by Dr. Matthew Rossheim at the George Mason University College of Health and Human Services provides important findings on how labeling of secondhand emissions from e-cigarettes can help more effectively communicate the harm from e-cigarettes and build support for tobacco-free campus policies.

16 Sep 2020

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife.

16 Sep 2020

New York City’s initial lockdown reduced coronavirus spread by 70 percent, study says

A team of researchers at Columbia University and the New York City Department of Health and Mental Hygiene have shown that this move by the government was effective in reducing the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19).

16 Sep 2020

CDC reports low mortality among children from COVID-19, but minorities are at risk

In the United States, the U.S. Centers for Disease Control and Prevention (CDC) reports 121 deaths among young people under the age of 21. Children from ethnic and racial minorities, those with underlying medical conditions, and in this age group, those between the ages of 18 and 20 are more likely to die from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.

16 Sep 2020

SARS-CoV-2 with D614G mutation is prevalent in central India

A team of scientists at the Defence Research and Development Establishment, India, reveals that there are multiple viral introduction events in central India, and SARS-CoV-2 with D614G mutation is the prevalently circulating strain.

16 Sep 2020

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

In a promising study by US researchers, the receptor-binding domain (RBD) and stabilized spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were displayed on nanoparticles as vaccine antigens and elicited potent immune responses.

16 Sep 2020

Low birth weight appears to increase risk of severe COVID-19 in adults

Researchers in Barcelona, Spain have conducted a study showing that low birth weight seems to be an independent risk factor for severe illness among non-elderly adults with coronavirus disease 2019 (COVID-19).

16 Sep 2020

Candidate monoclonal antibody shows hope as COVID-19 treatment

Researchers in the United States have described the effectiveness of a candidate monoclonal antibody currently being evaluated in a Phase 1 trial as a therapy for coronavirus disease 2019 (COVID-19) and its causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16 Sep 2020

Sub-Saharan Africa needs greater access to live-saving antibodies

Sub-Saharan Africa must increase access to live-saving, laboratory-produced antibodies, writes Yolanda Moyo.

16 Sep 2020

Tough to tell COVID from smoke inhalation symptoms — and flu season’s coming

The patients walk into Dr. Melissa Marshall's community clinics in Northern California with the telltale symptoms. They're having trouble breathing. It may even hurt to inhale. They've got a cough, and the sore throat is definitely there.

16 Sep 2020

Lack of antigen test reporting leaves country ‘blind to the pandemic’

More than 20 states either don't release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus, which has sickened more than 6 million Americans.

16 Sep 2020

COVID vaccine trials move at warp speed, but recruiting Black volunteers takes time

Participation in clinical trials among Black people is low, according to Food and Drug Administration statistics.

16 Sep 2020

Pfizer's anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2

Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act in synergism with the approved antiviral remdesivir to suppress viral replication in COVID-19.

16 Sep 2020

Critical insights into COVID-19 exposure for healthcare workers

A recent Northwestern University Feinberg School of Medicine study published in the preprint server medRxiv in September 2020 shows that the use of standard guidelines of infection control, including personal protective equipment (PPE), helps to prevent the undue risk of infection among HCWs as well.

16 Sep 2020

Heparan sulfate aids COVID-19 virus to penetrate human lung cells

A molecule known as ACE2 sits like a doorknob on the outer surfaces of the cells that line the lungs. Since January 2020, researchers have known that SARS-CoV-2, the novel coronavirus that causes COVID-19, primarily uses ACE2 to enter these cells and establish respiratory infections.

16 Sep 2020

New comparative performance data published for authorized COVID-19 molecular diagnostic tests

Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests.

16 Sep 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Higher viral loads can increase mortality rate in patients hospitalized with COVID-19 and cancer

Anti-CD73 molecule CPI-006 activates B cell responses to SARS-CoV-2

Azelastine antihistamine inhibits SARS-CoV-2 infection in nasal tissue in vitro

Changes in risk perception and protective behavior during coronavirus pandemic

Labeling e-cigarette emissions as 'chemicals' or 'aerosols' increases the perceived risk of exposure

Conditions linked to obesity leave the lungs of obese patients more susceptible to COVID-19

New York City’s initial lockdown reduced coronavirus spread by 70 percent, study says

CDC reports low mortality among children from COVID-19, but minorities are at risk

SARS-CoV-2 with D614G mutation is prevalent in central India

Self-assembling nanoparticles as a way towards next-generation COVID-19 vaccines

Low birth weight appears to increase risk of severe COVID-19 in adults

Candidate monoclonal antibody shows hope as COVID-19 treatment

Sub-Saharan Africa needs greater access to live-saving antibodies

Tough to tell COVID from smoke inhalation symptoms — and flu season’s coming

Lack of antigen test reporting leaves country ‘blind to the pandemic’

COVID vaccine trials move at warp speed, but recruiting Black volunteers takes time

Pfizer's anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2

Critical insights into COVID-19 exposure for healthcare workers

Heparan sulfate aids COVID-19 virus to penetrate human lung cells

New comparative performance data published for authorized COVID-19 molecular diagnostic tests

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in